Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oncology Institute (TOI) Share-based Compensation (2021 - 2025)

Oncology Institute's Share-based Compensation history spans 5 years, with the latest figure at $1.3 million for Q4 2025.

  • For Q4 2025, Share-based Compensation rose 2.17% year-over-year to $1.3 million; the TTM value through Dec 2025 reached $4.6 million, down 59.19%, while the annual FY2025 figure was $4.6 million, 59.19% down from the prior year.
  • Share-based Compensation reached $1.3 million in Q4 2025 per TOI's latest filing, up from $1.0 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $24.4 million in Q4 2021 to a low of $42000.0 in Q1 2021.
  • Average Share-based Compensation over 5 years is $4.3 million, with a median of $3.7 million recorded in 2023.
  • Peak YoY movement for Share-based Compensation: surged 20264.29% in 2022, then plummeted 77.8% in 2025.
  • A 5-year view of Share-based Compensation shows it stood at $24.4 million in 2021, then crashed by 75.11% to $6.1 million in 2022, then plummeted by 32.8% to $4.1 million in 2023, then plummeted by 68.4% to $1.3 million in 2024, then grew by 2.17% to $1.3 million in 2025.
  • Per Business Quant, the three most recent readings for TOI's Share-based Compensation are $1.3 million (Q4 2025), $1.0 million (Q3 2025), and $752000.0 (Q2 2025).